The Iowa R&D Tax Credit Phase-Down: Analyzing the Mechanism of Partial Refundability and Strategic Implications for Corporate Tax Planning
I. Executive Summary: The Nuance of Partial Refundability in Iowa R&D Tax Policy
A refundable tax credit is a mechanism that allows a taxpayer to receive the entire credit amount as a cash refund, even if the credit exceeds their total tax liability.1 In the context of the Iowa Research Activities Credit (RAC), the phrase “Subject to Phase-Down Limits” refers to a transitional legislative change (House File 2317) that incrementally reduces the percentage of the excess credit available as a cash refund each year through 2027.2
The structure of the Iowa RAC has historically been a critical element of the state’s economic competitiveness, offering significant liquidity to businesses engaged in qualified research. However, recent legislation has introduced complexity and uncertainty. The implementation of a rapid, annual phase-down of refundability (10 percentage points per year, starting in 2023) was a maneuver designed to immediately reduce the state’s fiscal exposure to the uncapped, refundable RAC program.2 This transitional period precedes the complete structural overhaul mandated by Senate File 657 (SF 657), which repeals the current tax entitlement structure effective January 1, 2026, and replaces it with a new, capped, and highly discretionary incentive program administered by the Iowa Economic Development Authority (IEDA).3 Strategic planning must therefore account for immediate cash flow restrictions imposed by the phase-down and the long-term shift from a tax entitlement to an economic development incentive.
II. Defining Refundability in State Tax Law: The Spectrum of Credit Mechanics
Understanding the mechanics of refundable credits is critical for corporate financial modeling, especially when evaluating the immediate liquidity provided by state incentives.
2.1. Refundable versus Nonrefundable Credits: A Critical Distinction for Liquidity
Tax credits generally fall into two categories. Nonrefundable tax credits reduce a company’s tax liability but cannot generate a cash refund. The savings derived from such credits are capped by the total amount of tax owed; if a $\$5,000$ nonrefundable credit is claimed but only $\$2,000$ in tax is owed, the $\$3,000$ excess cannot be paid out as cash.1 For R&D companies in startup phases or those experiencing losses, nonrefundable credits offer limited immediate liquidity, as the benefit is deferred until future profitable years.
Conversely, a fully refundable tax credit is treated as an overpayment, payable as cash directly to the taxpayer, regardless of whether a tax liability exists.1 Before 2023, the Iowa RAC was largely fully refundable, providing an immediate and potent boost to corporate cash flow and funding R&D activities.2
2.2. The Structure of Partially Refundable Credits (The Iowa Phase-Down Model)
The Iowa RAC, under House File 2317 (HF 2317), transitioned into a partially refundable credit system. This structure dictates that only a specific, statutorily mandated percentage of the excess credit (the portion remaining after the credit reduces the tax liability to zero) is available for a cash refund.4
A key technical detail involves the disposition of the non-refundable portion of the excess credit. Unlike typical nonrefundable credits which often allow extended carryforward periods (e.g., ten years for some Iowa credits 5), the RAC rules require the non-refunded percentage (e.g., 20% in tax year 2024) to be applied against the taxpayer’s liability for the immediately following tax year.2 This limitation has profound financial implications. If a business generates a substantial non-refundable excess in one year but fails to generate a sufficient Iowa tax liability in the subsequent year to fully utilize that deferred amount, the remaining credit effectively expires. This policy severely limits the time horizon for realizing the benefit of the non-refunded amount, compelling companies to focus on accurate two-year tax forecasting and diminishing the long-term financial value of that portion of the credit.
III. The Iowa Research Activities Credit (RAC): Pre-2026 Mechanics and IDR Guidance
The current structure of the RAC, administered by the Iowa Department of Revenue (IDR) under Iowa Code $\S 422.10$, follows a strict calculation methodology and set of eligibility requirements.
3.1. Foundation and Eligibility Restrictions (Iowa Code § 422.10)
The Iowa credit is structured similarly to the federal research tax credit (IRC Section 41) in its definition of Qualified Research Expenses (QREs), covering items such as wages and outside research expenses.2 However, only expenses incurred in Iowa can be captured for the state credit.6
A major constraint imposed on the credit is the strict limitation on eligible industries. Only businesses engaged in manufacturing, life sciences, agriscience, software engineering, or aviation and aerospace are eligible.2 The IDR provides critical clarifying guidance on the definition of these sectors, noting that “manufacturing” includes activities such as refining, purifying, combining different materials, packing of meats, and post-extractive processes like crushing, washing, or sizing of aggregate materials.8
3.2. Calculation Methodology: The Base Amount and the 50% Floor
The primary calculation method, known as the Regular Method, determines the credit as the sum of: (1) six and one-half percent (6.5%) of the excess of Iowa QREs over the established base amount, and (2) 6.5% of qualified basic research payments made during the tax year.9
The Base Amount is calculated as the product of the fixed-based percentage multiplied by the average annual gross receipts of the taxpayer for the four preceding taxable years.8 A critical compliance point reinforced by IDR guidance is the 50% Floor: the base amount may not be less than fifty (50) percent of the qualified research expenses (QREs) for the current credit year.8 This floor functions as an implicit cap, ensuring that the credit fundamentally rewards incremental research activity by always assuming a minimum baseline of 50% of current-year QREs is non-incremental. The IDR has stated this clarification applies to all tax years, past and present.8
Furthermore, starting in 2023, HF 2317 mandated that Iowa taxpayers must use the same calculation methodology (Regular Method or Alternative Simplified Credit—ASC) for the Iowa credit that they selected or were required to use for federal tax purposes.6 The Iowa ASC method offers a rate of 4.55% of expenditures exceeding 50% of the average of the prior three-year QREs.2
3.3. Supplemental Research Credits: The Economic Development Priority
Iowa utilizes a tiered incentive strategy, granting companies approved under the High-Quality Jobs (HQJ) Program or the Enterprise Zone Program access to a Supplemental Research Activities Credit.6 This supplemental credit provides an enhanced rate, offering up to an additional 10% of qualifying incremental research expense for small firms (those with gross revenues of $\le \$20$ million).6 The prioritization of these credits is further evidenced by the differing refundability rates applied during the phase-down period, where the Supplemental Credit often maintained a higher refund percentage than the Regular RAC.9 This differential structure highlights the state’s policy preference for R&D linked directly to measurable economic development outcomes such as job creation and capital investment.
IV. The Statutory Phase-Down Limit (HF 2317): Technical Analysis and Schedule
The phase-down of refundability, implemented by House File 2317 (2022), constitutes a necessary step in modeling the current cash flow value of the RAC. This measure was designed to immediately manage the state’s liability exposure ahead of the full repeal planned for 2026.2
4.1. Legislative Implementation and Policy Context
The legislative mechanism dictates an annual 10 percentage point reduction in the refundable portion of the excess credit. The phase-down commenced in tax year 2023 at 90% refundability and continues through tax year 2027, when it is slated to reach its final statutory floor of 50%.2 Taxpayers must apply the statutory limit based on the tax year for which the credit claim is filed.
4.2. Year-by-Year Phase-Down Schedule (IDR Compliance)
The following schedule outlines the maximum percentage of the credit in excess of the tax liability that can be refunded in cash:
Iowa Research Activities Credit Phase-Down Schedule (2023–2027)
| Tax Year (Begins On or After Jan 1) | RAC Regular Credit Refundability Limit | Non-Refundable Portion |
| 2023 | 90% | 10% |
| 2024 | 80% | 20% |
| 2025 | 70% | 30% |
| 2026 | 60% (Program Repealed Jan 1, 2026) 3 | 40% |
| 2027 and Later | 50% (Code Repealed Jan 1, 2027) 11 | 50% |
It is crucial to note the nuance regarding the Supplemental Research Credit, which often operates on a separate, more favorable refundability schedule. For instance, in 2024, while the Regular RAC was limited to 80% refundability, the Supplemental Credit often maintained a 90% refundability rate, as indicated by examples detailing the maximum refundable percentage for the Supplemental credit.9
4.3. Financial Implications of the Phase-Down
The incremental reduction in refundability directly impairs the immediate cash recovery for companies that rely on the credit to fund R&D operations. For firms with high research expenses and low or zero current tax liability, the $0.10$ annual reduction means a direct reduction in operating liquidity. Furthermore, the constraint limiting the non-refundable excess to offset only the subsequent year’s tax liability, without a long-term carryforward, creates a severe risk of credit expiration. If a company fails to become profitable quickly, the deferred credit value may be entirely lost, which fundamentally lowers the effective financial value of the credit relative to its nominal calculated amount.
V. Case Study: Applying the Phase-Down Mechanism (Tax Year 2024 Example)
A concrete example illustrates how the differential refundability limits applied during the transition period (prior to the 2026 repeal) affect a company’s realized cash benefit.
5.1. Establishing Qualified Research Expenditures and Credit Calculation
For the purpose of this analysis, the following assumptions are applied for Tax Year 2024:
- Iowa Qualified Research Expenses (QREs): $\$1,000,000$
- Current Iowa Tax Liability: $\$10,000$
- Base Amount (Calculated per IDR rules, minimum 50% floor applied): $\$500,000$ 8
- HQJ Eligibility: Yes (Qualifies as a small firm for 10% Supplemental Credit) 6
Calculation Steps (Regular Method – Current RAC):
- Determine Excess QREs: Current QREs $(\$1,000,000)$ minus Base $(\$500,000)$ equals $\$500,000$.9
- Calculate Regular RAC: $6.5\% \times \$500,000 = \$32,500$.10
- Calculate Supplemental RAC: $10\% \times \$500,000 = \$50,000$.9
- Gross Credit Total: $\$32,500 + \$50,000 = \$82,500$.
5.2. Application Against Tax Liability and Determining Excess
The gross credit of $\$82,500$ is first utilized to eliminate the $\$10,000$ tax liability. This leaves an Excess Credit Subject to Phase-Down of $\$72,500$.
5.3. Step-by-Step Application of the 80% and 90% Refundable Limits
The $\$72,500$ excess credit must be separated into its component parts (Regular and Supplemental) to apply the appropriate refundability rates for 2024 (80% for Regular RAC; 90% for Supplemental Credit).2
Case Study Table: Phase-Down Impact Analysis (Tax Year 2024)
| Credit Component (Excess) | Calculated Excess Credit | Refundable Limit (2024) | Final Refundable Cash Amount | Non-Refundable Excess (Deferred to 2025) |
| RAC Regular Credit | $32,500$ | $80\%$ | $26,000$ | $6,500$ $(20\%)$ |
| Supplemental Credit | $40,000$ | $90\%$ | $36,000$ | $4,000$ $(10\%)$ |
| Tax Offset (Initial Reduction) | $10,000$ | $100\%$ | N/A | N/A |
| Total Impact | $82,500 | N/A | $62,000$ | $10,500$ |
5.4. Outcome Analysis: Financial Strategy
In this example, the taxpayer receives an immediate cash refund of $62,000. The deferred amount of $10,500 (the non-refundable portion) must be carried forward and applied solely against the company’s 2025 Iowa tax liability.2 This deferred credit cannot be carried forward beyond 2025; if the tax liability in 2025 is less than $\$10,500$, the remainder of the credit is lost, emphasizing the need for short-term profitability to capture the full economic value of the R&D investment.
VI. The Looming Transition: Repeal and the New IEDA Program (SF 657)
Effective for tax years beginning on or after January 1, 2026, the Iowa R&D credit program undergoes a fundamental structural transformation, moving from a standard tax provision to a capped, discretionarily awarded economic incentive.
6.1. Legislative Sunset and Repeal (SF 657)
Senate File 657 (SF 657), passed in May 2025, dictates the repeal of the existing Research Activities Credit (RAC) for tax years beginning in 2026.3 The credit will be formally repealed from the Iowa Code on January 1, 2027.11 It is noted that the rights to previously issued or awarded RAC credits, including any associated tax credit carryforward amounts, are preserved if they were issued or allowed before July 1, 2026.12
6.2. Introduction of the New R&D Tax Credit Program (IEDA Administration)
The legislative shift replaces the RAC with a new R&D Tax Credit Program administered by the Iowa Economic Development Authority (IEDA).13 This change is critical because it fundamentally converts the credit from a tax entitlement (claimed directly on a tax return under IDR rules if eligibility criteria are met) to a competitive program where approval is based on IEDA discretion and budgetary limits.
The new calculation methodology also changes substantially. The former credit rewarded incremental spending (6.5% of QREs over the base amount). The new program offers a maximum credit of up to 3.5% of a business’s total Qualified Research Expenses (QREs).13 Although the rate is lower, the credit is applied against the total QREs rather than just the incremental amount. For certain mature companies with stable, but non-increasing, R&D expenditures, the change in the calculation base might mitigate the reduction in rate, though the overall complexity and risk have increased due to the imposition of a cap.
6.3. Analyzing the $40 Million Annual Cap and Discretionary Approval
The most significant strategic challenge presented by the IEDA-administered program is the hard cap on the total amount of credits issued each year, limited to $\$40$ million.3
To receive the credit, businesses must now pre-apply with the IEDA, which determines whether the company fits the qualifying sector and engages in qualifying research.13 The IEDA has substantial discretion in approving applicants and allocating the finite pool of funds.13 The existence of a hard cap fundamentally transforms R&D tax planning from a compliance exercise into a competitive strategy. Companies are no longer guaranteed the credit simply by meeting statutory research definitions; they must compete effectively for a finite pool of state funds. This substitution of tax certainty with budgetary competition necessitates a proactive approach to demonstrating economic value.
6.4. Enhanced Reporting Requirements
The IEDA program further enforces its economic development focus through enhanced reporting requirements. Approved businesses must file an annual report detailing the amount of R&D investment made, the precise location of the R&D within Iowa, the number of jobs created, the associated wages paid for those jobs, and where the employees reside.13 This comprehensive disclosure mandate confirms the policy intent: the new R&D credit is heavily conditioned upon verifiable, positive economic outcomes (jobs and wages), signaling a definitive departure from a purely tax-based incentive structure.
VII. Conclusion and Advisory Recommendations for Tax Planning
The transition of the Iowa R&D tax credit from a generous, uncapped tax entitlement to a capped, discretionary economic development program creates two distinct sets of compliance and financial challenges for R&D-intensive businesses.
7.1. Navigating Current Compliance and Cash Flow (2024/2025)
For the immediate future, tax teams must ensure precision in applying the phase-down limits imposed by HF 2317.
- Phase-Down Modeling: It is essential to model the credit’s effective cash value based on the annual statutory percentage (e.g., 80% for the Regular RAC in 2024 and 70% in 2025) applied only to the excess credit amount.2
- Tiered Refundability: For companies benefiting from the HQJ or Enterprise Zone programs, the higher refundability rate often applied to the Supplemental Credit (e.g., 90%) must be utilized to maximize immediate cash recovery.9
- Deferred Credit Management: Due to the severe limitation on carryforward—the non-refundable excess must be applied solely against the subsequent year’s liability—companies must integrate the deferred credit value into their 2025 estimated tax payments. Failure to generate sufficient Iowa tax liability in the subsequent year will result in the expiration and loss of the non-refundable portion of the credit.2
7.2. Strategic Forecasting for the 2026 Transition
The long-term strategy must pivot from compliance to competitive pursuit of the new IEDA credit.
- Competitive Application Preparation: Companies must recognize that the $\$40$ million annual cap under the new IEDA program dictates a competitive application process.3 Future success will depend on the ability to demonstrate, via pre-application and annual reporting, a direct and substantial correlation between R&D investment and high-quality job creation in Iowa, rather than simply meeting technical IRC $\S41$ rules.13
- Credit Calculation Shift: Tax planners should forecast the impact of the shift from a 6.5% incremental calculation to the 3.5% total QRE calculation, recognizing that while the rate is lower, the base is broader. However, the availability of the credit is now subject to IEDA approval and the budgetary cap, introducing significant strategic uncertainty that must be factored into future investment decisions.
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state










